Please use this identifier to cite or link to this item:
Title: Severe weight gain in 2 boys treated with risperidone
Authors: Nelissen, Sanne
Issue Date: 2010
Source: Tijdschrift van de Belgische Kinderarts, 12 (4), p. 48-49
Abstract: Weight gain is a frequent side effect of treatment with atypical antipsychotics in adults as well as in children, but the prevalence and severity are still far underestimated. We here report on 2 boys who developed severe overweight during treatment with risperidone. An 8.5 years old boy more than doubled his weight during 4 years of treatment with risperidone resulting in a BMI increase from 17.0 kg/m² (+ 0.6 SDS) to 29.6 kg/m² (+ 2.9 SDS) at the age of 12.4 yrs. A 12.3 years old boy, treated since the age of 9.1 years with risperidone, also doubled his weight during 3 years of treatment with an increase in BMI from 16.4 kg/m² (+ 0.1 SDS) to 26.0 kg/m² (+ 1.9 SDS). Auxological and metabolic parameters should carefully be followed-up in all children treated with atypical antipsychotics and weight stabilising or reducing actions should be taken as soon as indicated.
Keywords: atypical antipsychotics; obesity; risperidone; weight gain
Document URI:
ISSN: 2032-3891
Category: A2
Type: Journal Contribution
Appears in Collections:Research publications

Files in This Item:
File Description SizeFormat 
Nelissen, Bervoets, Massa (2010) Severe WG boys risperidone.pdfCase Report92.46 kBAdobe PDFView/Open
Show full item record

Page view(s)

checked on May 25, 2022


checked on May 25, 2022

Google ScholarTM


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.